These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26318280)

  • 1. The phototoxicity of vemurafenib: An investigation of clinical monochromator phototesting and in vitro phototoxicity testing.
    Woods JA; Ferguson JS; Kalra S; Degabriele A; Gardner J; Logan P; Ferguson J
    J Photochem Photobiol B; 2015 Oct; 151():233-8. PubMed ID: 26318280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vemurafenib: an unusual UVA-induced photosensitivity.
    Gelot P; Dutartre H; Khammari A; Boisrobert A; Schmitt C; Deybach JC; Nguyen JM; Seité S; Dréno B
    Exp Dermatol; 2013 Apr; 22(4):297-8. PubMed ID: 23528218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phototoxicity of B-RAF inhibitors: Exclusively due to UVA radiation and rapidly regressive.
    Gabeff R; Dutartre H; Khammari A; Boisrobert A; Nguyen JM; Quereux G; Brocard A; Saint-Jean M; Peuvrel L; Dreno B
    Eur J Dermatol; 2015; 25(5):452-6. PubMed ID: 26242321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vemurafenib skin phototoxicity is indirectly linked to ultraviolet A minimal erythema dose decrease.
    Brugière C; Stefan A; Morice C; Cornet E; Moreau A; Allouche S; Verneuil L
    Br J Dermatol; 2014 Dec; 171(6):1529-32. PubMed ID: 25066094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay Between Membrane Lipid Peroxidation and Photoproduct Formation in the Ultraviolet A-Induced Phototoxicity of Vemurafenib in Skin Keratinocytes.
    Teixeira A; Morlière P; Ferreira J; Conte MA; Galmiche A; Mazière JC; Santus R; Filipe P
    Toxicol Sci; 2016 Dec; 154(2):289-295. PubMed ID: 27566444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of vemurafenib phototoxicity in a mouse model.
    Boudon SM; Plappert-Helbig U; Odermatt A; Bauer D
    Toxicol Sci; 2014 Jan; 137(1):259-67. PubMed ID: 24154489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tinea hidden by a vemurafenib-induced phototoxic reaction in a patient with metastatic melanoma taking dexamethasone.
    Anforth R; Carlos G; Eiris N; Clements A; Fernandez-Peñas P
    Med J Aust; 2015 Jul; 203(1):41-2. PubMed ID: 26126567
    [No Abstract]   [Full Text] [Related]  

  • 8. Vemurafenib in patients with BRAF V600E mutation-positive advanced melanoma.
    Ravnan MC; Matalka MS
    Clin Ther; 2012 Jul; 34(7):1474-86. PubMed ID: 22742884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet A and photosensitivity during vemurafenib therapy.
    Dummer R; Rinderknecht J; Goldinger SM
    N Engl J Med; 2012 Feb; 366(5):480-1. PubMed ID: 22296092
    [No Abstract]   [Full Text] [Related]  

  • 10. Case series: indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma.
    Boudewijns S; Gerritsen WR; Koornstra RH
    BMC Cancer; 2014 Dec; 14():967. PubMed ID: 25515496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation-positive metastatic melanoma, including recognition and management of rare presentations.
    Sinha R; Larkin J; Gore M; Fearfield L
    Br J Dermatol; 2015 Oct; 173(4):1024-31. PubMed ID: 26109403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.
    Larkin J; Del Vecchio M; Ascierto PA; Krajsova I; Schachter J; Neyns B; Espinosa E; Garbe C; Sileni VC; Gogas H; Miller WH; Mandalà M; Hospers GA; Arance A; Queirolo P; Hauschild A; Brown MP; Mitchell L; Veronese L; Blank CU
    Lancet Oncol; 2014 Apr; 15(4):436-44. PubMed ID: 24582505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vemurafenib-induced pityriasis amiantacea: a case report.
    Bilgiç Ö
    Cutan Ocul Toxicol; 2016 Dec; 35(4):329-31. PubMed ID: 26513697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vemurafenib. Value unclear in metastatic melanoma.
    Prescrire Int; 2012 Dec; 21(133):288-90. PubMed ID: 23373092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity.
    Dawe RS; Ibbotson SH; Sanderson JB; Thomson EM; Ferguson J
    Br J Dermatol; 2003 Dec; 149(6):1232-41. PubMed ID: 14674902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyrin accumulation in humans with common dysfunctional variants of ABCG2, a porphyrin transporter: potential association with acquired photosensitivity.
    Sakiyama M; Matsuo H; Toyoda Y; Yonekura Y; Ishikawa T; Nakayama A; Higashino T; Kawamura Y; Fujimoto N; Shinomiya N; Satoh T
    Hum Cell; 2021 Jul; 34(4):1082-1086. PubMed ID: 34009629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
    Vanneste L; Wolter P; Van den Oord JJ; Stas M; Garmyn M
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):61-8. PubMed ID: 24661317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation.
    Roh MR; Kim JM; Lee SH; Jang HS; Park KH; Chung KY; Rha SY
    J Dermatol; 2015 Sep; 42(9):881-8. PubMed ID: 26047064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag (75 mg) does not induce photosensitivity: results of a clinical pharmacology trial.
    Bowen CJ; Lobb KM; Park JW; Sanderson B; Ferguson J
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):243-9. PubMed ID: 20831698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of vemurafenib in Australian patients with unresectable or metastatic melanoma containing the V600 BRAF gene mutation.
    Brown MP; Long GV
    Asia Pac J Clin Oncol; 2014 Apr; 10 Suppl S3():1-15. PubMed ID: 24712861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.